Evidence map›Paper›PMID 10614865›Full record

ArticleIn vitro cellular & developmental biology. Animal

Effects of commonly used mitogens on the cytotoxicity of 4-tertiary butylphenol to human melanocytes.

F Yang, Z Abdel-Malek, R E Boissy

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

F YangDepartment of Dermatology, University of Cincinnati College of Medicine, Ohio 45267, USA.
Z Abdel-Malek
R E Boissy
University of Cincinnati · US

Funding

PHENOLS/CATECHOLS IN OCCUPATIONAL/CONTACT VITILIGO SKINR01AR046115 · NIAMS · UNIVERSITY OF CINCINNATI · PI BOISSY, RAYMOND E · 2000 to 2002
$765k
NIAMS NIH HHS AR46115
6 · The paper itself

Abstract

In the search for environmental compounds responsible for contact or occupational vitiligo, it was found that the most potent was 4-tertiary butylphenol (4-TBP). Exposure to 4-TBP is widespread both in industry and in consumer items including synthetic leather, plastic, glues, and germicidal phenolic detergents. How 4-TBP causes depigmentation and the death of melanocytes is currently unclear. Growth mitogens for human melanocytes include alpha-melanocyte stimulating hormone (alpha-MSH), basic fibroblast growth factor (bFGF) and 12-o-tetradecanoylphorbol-13-acetate (TPA). The former two mitogens are physiological growth factors for melanocytes. We have studied the effects of these mitogens on the cytotoxicity of 4-TBP in human melanocytes. Our results demonstrated that deprivation of alpha-MSH or bFGF from melanocyte cultures resulted in reduced cytotoxicity to 4-TBP. Similar results were obtained upon treatment of melanocytes with an inhibitor of cAMP-dependent protein kinase A (PKA), that is known to be activated by alpha-MSH, or with an inhibitor of the tyrosine kinase bFGF receptor. In contrast, removal of fetal bovine serum or TPA from the culture medium did not influence the susceptibility of melanocytes to 4-TBP. These results suggest that activation of the cAMP and tyrosine kinase signaling pathways, both of which are involved in the mitogenic response of melanocytes, increase the susceptibility of these cells to the cytotoxic effects of 4-TBP.

Indexed as

alpha-MSHAnimalsBloodCattleCells, CulturedCell SurvivalCyclic AMPCyclic AMP-Dependent Protein KinasesFibroblast Growth Factor 2HumansMelanocytesMitogensPhenolsTetradecanoylphorbol Acetatealpha-MSHbutylphenCyclic AMPCyclic AMP-Dependent Protein KinasesFibroblast Growth Factor 2MitogensPhenolsTetradecanoylphorbol Acetate

Identifiers

PMID10614865
OpenAlexW1993023020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.